Udall Center Director's meeting poster award

太平洋西北尤德尔中心（PANUC）是俄勒冈州健康与科学大学和华盛顿大学的医生和科学家之间的合作企业，专注于认知障碍的大量经验和专业知识，认知障碍是一种相对鲜为人知但毁灭性的后果，在帕金森病（PD）患者中很常见。这个拟议中的新Udall中心将是俄勒冈州或WWAMI地区唯一的一个; WWAMI是太平洋西北部各州之间合作安排的首字母缩写，其中华盛顿大学是唯一的医学院和学术医疗中心：华盛顿，怀俄明州，阿拉斯加州，蒙大拿州和爱达荷州。因此，PANUC将覆盖整个美国四分之一以上的地区，超过1300万美国人居住。PANUC将实现NIH和NINDS的几个目标。PANUC是：突出以患者为导向，专注于PD的一个常见的非运动特征，该特征相对缺乏了解，被组织成高度相关的核心和项目，这将促进临床，转化和基础研究之间的新知识交流，渴望为PD数据组织中心（PD-DOC）和Coriell研究所做出充分贡献，以提交给NINDS人类遗传学知识库，而且由调查人员组成，他们尽管在两个机构工作，但长期以来都有高度合作的生产力记录。我们的使命是双重的。首先，PANUC将为PD患者提供服务，沿着他们的护理人员和医疗保健提供者。我们将提供更好的教育和临床护理，并提供参与临床研究的新机会。其次，PANUC将使用来自成熟和合作实验室的一系列尖端技术发现和研究PD认知障碍的机制，为专注于PD的科学家社区创造新的资源，并确定未来治疗开发的潜在目标。

The Pacific Northwest Udall Center (PANUC) is a collaborative enterprise among physicians and scientists at Oregon Health & Science University and the University of Washington that focuses considerable experience and expertise on cognitive impairment, a relatively poorly understood but devastating consequence that is common in patients afflicted with Parkinson's disease (PD). This proposed new Udall Center would be the only one in Oregon or the WWAMl region; WWAMI is an acronym for the cooperative arrangement among states in Pacific Northwest for which the University of Washington is the only medical school and academic medical center: Washington, Wyoming, Alaska, Montana, and Idaho. Thus, PANUC would cOver an area greater than one-fourth of the entire U.S.A. where more than 13 million Americans live. PANUC will achieve several goals of the NIH and NINDS. PANUC is: eminently patient-oriented, focused on a common non-motor feature of PD that is relatively poorly understood, organized into highly inter-related cores and projects that will promote exchange of new knowledge among clinical, translational, and basic research, anxious to contribute fully to the PD Data Organizing Center (PD-DOC) and the Coriell Institute for submission to the NINDS Human Genefics Repository, and composed of investigators who have a longstanding track record of highly collaborative productivity despite being at two institutions. Our mission is twofold. First, PANUC will serve PD patients, along with their caregivers and health care providers. We will provide improved education and clinical care, as well as offer new opportunities to participate in clinical research. Second, PANUC will discover and investigate the mechanisms that underlie cognitive impairment in PD using an array of cutting-edge technologies from accomplished and collaborative laboratories, generating novel resources for the community of scientists focused on PD, and identifying potential targets for future therapeutic development.